title: Cathepsin D cytosolic assay and immunohistochemical quantification in human prostate tumors.
abstract: We quantified cathepsin D by immunoradiometric assay (IRMA) and quantitative immunohistochemistry in fifteen human prostate cancers, seventeen BPH, and nine normal prostates. The cytosolic cathepsin D concentration was higher in prostatic carcinoma (mean: 31.5 pmol/mg cytosol proteins; range: 10.2-66.2) than in normal prostate (16.0 pmol/mg cytosol proteins; 7.2-25.5; P = 0.01). Prostatic hyperplasia showed intermediate values (20.2 pmol/mg cytosol proteins; 7.6-33.9). Immunostaining of cathepsin D and prostatic acid phosphatase on serial frozen sections of prostate tissues was only observed in glandular epithelial cells. Immunostaining was quantified by computer-assisted image analysis as an quantitative immuno-cytochemical score (QIC score) expressed in arbitrary units (A.U.). QIC scores for cathepsin D were dispersed and had a tendency to be higher in benign prostatic hyperplasia (mean: 178.3 A.U.; range: 95-297) compared to normal prostate (85.2 A.U.; 2-173 P < 0.01) and prostatic carcinoma (90.0 A.U.; 21-179 P = 0.0002). Prostatic cathepsin D levels in cytosols or immunostaining sections were independent of other clinicobiological parameters.
authors.affiliation: Laboratoire de Biologie Cellulaire and INSERM U148, Montpellier, France.
authors.forename: M
authors.initials: M
authors.lastname: Chambon
authors.forename: X
authors.initials: X
authors.lastname: Rebillard
authors.forename: H
authors.initials: H
authors.lastname: Rochefort
authors.forename: J P
authors.initials: JP
authors.lastname: Brouillet
authors.forename: P
authors.initials: P
authors.lastname: Baldet
authors.forename: J
authors.initials: J
authors.lastname: Guiter
authors.forename: T
authors.initials: T
authors.lastname: Maudelonde
mesh_terms: D000135:Acid Phosphatase / Q000097:blood; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002402:Cathepsin D / Q000032:analysis*; D003600:Cytosol / Q000201:enzymology / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011467:Prostate / Q000201:enzymology / Q000473:pathology*; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000201:enzymology / Q000473:pathology* / Q000601:surgery; D012016:Reference Values; D001749:Urinary Bladder Neoplasms / Q000201:enzymology / Q000473:pathology / Q000601:surgery
chemical_list: D000135:Acid Phosphatase; D017430:Prostate-Specific Antigen; D002402:Cathepsin D